4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001878824-26-000001
Chief Financial Officer gave up 9,748 shares (to pay taxes)
- Chief Financial Officer acquired 23,721 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2026-03-10 | Option exercise | +6,320 | 87,034 | D | ||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Shares withheld for taxes | −2,603 | $4.23 | $11,011 | 84,431 | D |
| McCombe William D. Chief Financial Officer | 2026-03-10 | Option exercise | +17,401 | 101,832 | D | ||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Shares withheld for taxes | −7,145 | $4.23 | $30,223 | 94,687 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Grant or award · Employee Stock Option (right to buy) | +136,205 | 136,205 | D | ||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Grant or award · Restricted Stock Units | +256,790 | 256,790 | D | ||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Option exercise · Restricted Stock Units | −6,320 | 56,889 | D | ||
| McCombe William D. Chief Financial Officer | 2026-03-10 | Option exercise · Restricted Stock Units | −17,401 | 156,613 | D | ||
Loading xslF345X05/form4-03122026_080323.xml…